Bosch and R-Biopharm join forces to enhance Vivalytic analysis platform through new medical technology partnership

Bosch and R-Biopharm Announce Partnership to Develop Innovative PCR Tests for Multiresistant Bacteria Thursday 18 April, 2024 – Bosch and R-Biopharm have announced a new partnership to develop PCR tests for multiresistant gram-negative (MRGN) bacteria using Bosch’s innovative BioMEMS technology. The two companies will be jointly investing 150 million euros in the development and marketing of these…

Source